Benzinga | Aug 12, 2021 04:21PM EDT

ImmuCell Q2 EPS $0.02 Up From $(0.11) YoY, Sales $4.54M Miss $5.40M Estimate

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.02 per share. This is a 118.18 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $4.54 million which missed the analyst consensus estimate of $5.40 million by 15.89 percent. This is a 53.14 percent increase over sales of $2.97 million the same period last year.